All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity.
Saved in:
| Title: | All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity. |
|---|---|
| Authors: | Hasbullah JS; Department of Medical Genetics, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.; British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada., Scott EN; Department of Medical Genetics, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.; British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada., Bhavsar AP; Department of Medical Microbiology and Immunology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada., Gunaretnam EP; British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada., Miao F; British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada., Soliman H; School of Biomedical Engineering, The University of British Columbia, Vancouver, British Columbia, Canada., Carleton BC; Department of Medical Genetics, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.; British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Department of Pediatrics, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada., Ross CJD; Department of Medical Genetics, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.; British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada. |
| Source: | PloS one [PLoS One] 2022 Nov 04; Vol. 17 (11), pp. e0276541. Date of Electronic Publication: 2022 Nov 04 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0276541 |
